MD
Mitesh Daga
About Mitesh Daga
Data last updated:
Mitesh Daga was an Additional Director at Sai Life Sciences Limited (2018), Additional Director at R R Kabel Limited (2018) and Additional Director at Sai Life Pharma Private Limited (2019–2020), and held 3 more directorships. The companies operate in Pharma, Manufacturing and Internet.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 30 Jul 2018 | 1999 | ₹1,731 Cr (FY 2025) | Active | |
| Additional Director | 06 Sep 2018 | 1995 | ₹9,779 Cr (FY 2026) | Active | |
| Additional Director | 09 Nov 2019 | 2019 | ₹3.02 Cr (FY 2025) | Active | |
| Additional Director | 26 Feb 2021 | 2017 | ₹21.26 Cr (FY 2022) | Active | |
| Additional Director | 29 May 2020 | 2010 | ₹10,521 Cr (FY 2026) | Active | |
| Director | 06 Sep 2018 | 1989 | ₹151 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mitesh Daga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitesh Daga
Mitesh Daga was first appointed on 30 Jul 2018 as Additional Director at Sai Life Sciences Limited. The most recent appointment on record is 26 Feb 2021 at Terrals Technologies Private Limited.
Mitesh Daga held 6 earlier board appointments: Sai Life Sciences Limited (Additional Director, 30 Jul 2018 to 26 Sep 2018); R R Kabel Limited (Additional Director, 06 Sep 2018 to 11 Sep 2018); Sai Life Pharma Private Limited (Additional Director, 09 Nov 2019 to 27 Oct 2020); Terrals Technologies Private Limited (Additional Director, 26 Feb 2021 to 26 Feb 2021); Manipal Health Enterprises Limited (Additional Director, 29 May 2020 to 15 Oct 2020); and 1 more.